Sewage Sludge Electro-Dewatering

Original sludge from wastewater treatment plants (WWTPs) usually has a poor dewaterability. Conventionally, mechanical dewatering methods are used to increase the dry solids (DS) content of the sludge. However, sludge dewatering is an important economic factor in the operation of WWTPs, high water content in the final sludge cake is commonly related to an increase in transport and disposal costs. Electro‐dewatering could be a potential technique to reduce the water content of the final sludge cake, but the parameters affecting the performance of electro‐dewatering and the quality of the resulting sludge cake, as well as removed water, are not sufficiently well known. In this research, non‐pressure and pressure‐driven experiments were set up to investigate the effect of various parameters and experimental strategies on electro‐dewatering. Migration behaviour of organic compounds and metals was also studied. Application of electrical field significantly improved the dewatering performance in comparison to experiments without electric field. Electro‐dewatering increased the DS content of the sludge from 15% to 40 % in non‐pressure applications and from 8% to 41% in pressure‐driven applications. DS contents were significantly higher than typically obtained with mechanical dewatering techniques in wastewater treatment plant. The better performance of the pressure‐driven dewatering was associated to a higher current density at the beginning and higher electric field strength later on in the experiments. The applied voltage was one of the major parameters affecting dewatering time, water removal rate and DS content of the sludge cake. By decreasing the sludge loading rate, higher electrical field strength was established between the electrodes, which has a positive effect on an increase in DS content of the final sludge cake. However interrupted voltage application had anegative impact on dewatering in this study, probably because the off‐times were too long. Other factors affecting dewatering performance were associated to the original sludge characteristics and sludge conditioning. Anaerobic digestion of the sludge with high pH buffering capacity, polymer addition and freeze/thaw conditioning had a positive impact on dewatering. The impact of pH on electro‐dewatering was related to the surface charge of the particles measured as zeta‐potential. One of the differences between electro‐dewatering and mechanical dewatering technologies is that electro‐dewatering actively removes ionic compounds from the sludge. In this study, dissolution and migration of organic compounds (such as shortchain fatty acids), macro metals (Na, K, Ca, Mg, Fe) and trace metals (Ni, Mn, Zn, Cr) was investigated. The migration of the metals depended on the fractionation and electrical field strength. These compounds may have both negative and positive impacts on the reuse and recycling of the sludge and removed water. Based on the experimental results of this study, electro‐dewatering process can be optimized in terms of dewatering time, desired DS content, power consumption and chemical usage.

18F-Labeled Presynaptic Dopaminergic Tracers. Synthesis, Radiochemical Analyses, and Preclinical Evaluation of [18F]FDOPA and [18F]CFT

Dysfunction of the dopaminergic system in brain is involved in several pathological conditions such as Parkinson’s disease and depression. 2β-Carbomethoxy-3β-(4-[18F] fluorophenyl)tropane ([18F]CFT) and 6-[18F]fluoro-L-dopa ([18F]FDOPA) are tracers for imaging the dopaminergic function with positron emission tomography (PET). Peripheral uptake of [18F]FDOPA is also used in the localization and diagnosis of neuroendocrine tumors. [18F]FDOPA and [18F]CFT can be synthesized by electrophilic fluorodestannylation. However, the specific radioactivity (SA) in the electrophilic fluorination is low with traditional synthetic methods. In this study, [18F]FDOPA and [18F]CFT were synthesized using post-target-produced [18F]F2 as an electrophilic fluorination agent. With this method, tracers are produced with sufficient SA for neuroreceptor studies. Specific aims in this study were to replace Freon-11 in the production of [18F]FDOPA due to the ozone depleting properties of this solvent, to determine pharmacological specificity and selectivity of [18F]CFT with respect to monoamine transporters, and to compare the ability of these tracers to reflect the degree of nigral neuronal loss in rats in which the dopaminergic system in the brain had been unilaterally destroyed by 6- OHDA. Post-target-produced [18F]F2 was successfully used in the production of [18F]FDOPA and [18F]CFT. The SA achieved was substantially higher than in previous synthetic methods. Deuterated compounds, CD2Cl2, CDCl3 and C3D6O, were found to be suitable solvents for replacing Freon-11. Both [18F]FDOPA and [18F]CFT demonstrated nigrostriatal dopaminergic hypofunction and correlated with the number of nigral dopaminergic neurons in the 6-OHDA lesioned rat. However, the dopamine transporter (DAT) tracer [18F]CFT was more sensitive than the dopamine synthesis tracer [18F]FDOPA in detecting these defects because of the higher non-specific uptake of [18F]FDOPA. [18F]CFT can also be used for imaging the norepinephrine transporter (NET) because of the specific uptake into the locus coeruleus. The observation that [18F]CFT exhibits specific uptake in the pancreas warrants further studies in humans with respect to potential utility in pancreatic imaging

Imaging of Dopamine and Serotonin Transporters. Pre-clinical Studies with Radiotracers for Positron Emission Tomography

The action of the neurotransmitters dopamine (DA) and serotonin (5-HT) at synapses is terminated by their rapid reuptake into presynaptic nerve endings via plasma membrane dopamine (DAT) and serotonin (SERT) transporters. Alterations in the function of these transporters have been suggested as a feature of several neurological and neuropsychiatric diseases, such as Parkinson’s disease (PD), depression, and anxiety. A suitable clinical method for studying these transporters non-invasively in vivo is positron emission tomography (PET) utilizing radiopharmaceuticals (tracers) labelled with short-lived positron-emitting radionuclides. The aim of this study was to evaluate in rats two novel radiotracers, [¹⁸F]beta -CFT-FP and ¹⁸FFMe-McN, for imaging DAT and SERT, respectively, using in vitro, ex vivo and in vivo methods. Substituting an N-methyl in [¹⁸F]beta-CFT, a well known DAT tracer, with a ¹⁸Ffluoropropyl group significantly changed the properties of the tracer. [¹⁸F]beta- CFT showed slow kinetics and metabolism, and a high specific uptake in the striatum, whereas [¹⁸F]beta-CFT-FP showed fast kinetics and metabolism, and a moderate specific uptake in the striatum. [¹⁸F]betaCFT-FP was selective for DAT; but [¹⁸F]beta-CFT also bound to the noradrenaline transporter. [¹⁸F]beta-CFT-FP may be a suitable PET tracer for imaging the striatal DAT sites, but a tracer with a higher affinity is needed for imaging extrastriatal DAT sites. In rats, ¹⁸FFMe-McN showed high target-to-non-target ratios, specificity and selectivity for SERT, but slow kinetics. However, ¹⁸FFMe-McN reveals potential for imaging SERT, at least in pre-clinical studies. In addition, the sensitivities of [¹⁸F]beta CFT and [¹⁸ F]FDOPA (a precursor of DA) for detecting mild nigrostriatal hypofunction were compared in an animal model of PD. The uptake of [¹⁸F]FDOPA was significantly affected by compensatory effects in dopaminergic cells, whereas [¹⁸F]beta-CFT was more sensitive and therefore more suitable for PET studies of mild dopaminergic symptoms. In conclusion, both novel tracers, [¹⁸F]-CFT-FP and ¹⁸FFMe-McN, have potential, but are not optimal PET tracers for DAT and SERT imaging in rats, respectively. [¹⁸F]beta-CFT is superior to [18F]FDOPA for imaging mild nigral lesions in rat brains.